Clinical Trial Update: SubQStim: A Post-market Study of Subcutaneous Nerve Stimulation in Failed Back Surgery Syndrome (FBSS) Patients [NA]

View source ↗

Summary

A post-market study of Subcutaneous Nerve Stimulation in patients with Failed Back Surgery Syndrome has been terminated, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Failed Back Surgery Syndrome

Drugs mentioned

• SubQStim (subcutaneous nerve stimulation)

Snippet

Sponsor: MedtronicNeuro | Conditions: Failed Back Surgery Syndrome | NA | Status: TERMINATED | Results posted: 2018-10-22